患者管理:过渡期垂体激素替代治疗的管理
儿童期垂体功能减退症是一种罕见、复杂的疾病,表型高度可变,可延续至成年。本文通过4例不同病因和临床表现的垂体功能减退症病例,讨论从临床表现到青年成年的诊断和管理过程,特别关注过渡期的需求和结局。
要点
- 垂体功能减退症在儿童期罕见且复杂,表型高度可变,可延续至成年。
- 垂体缺陷可随时间演变,模式不可预测,导致显著发病率和死亡率。
- 过渡期是垂体功能减退症患者的关键医疗时期,需处理青春期、身高达标、治疗依从性和终身用药接受度等复杂问题。
核心结论
- 过渡期是垂体功能减退症患者的关键医疗时期,需处理青春期、身高达标、治疗依从性和终身用药接受度等复杂问题。
- 对于医疗专业人员,过渡期是重新评估垂体缺陷和终身替代治疗需求的机会,通常背景是复杂的心理问题。
研究设计与样本
- 本文为患者管理综述,呈现4例不同病因和临床表现的垂体功能减退症 illustrative 病例,讨论从临床表现到青年成年的诊断和管理过程。
主要发现
- 垂体功能减退症在儿童期罕见且复杂,表型高度可变,可延续至成年。
- 垂体缺陷可随时间演变,模式不可预测,导致显著发病率和死亡率。
- 垂体功能减退症和下丘脑功能障碍可能伴随肥胖、学习困难、行为问题、睡眠障碍和视力损害等挑战性合并症。
临床怎么用
- 为实现医疗环境中的有效过渡,必须认识到从依赖儿童向独立成人演变的内在挑战。
- 过渡期需处理青春期、身高达标、治疗依从性和终身用药接受度等复杂问题。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hypopituitarism in childhood is a rare, complex disorder that can present with highly variable phenotypes, which may continue into adult life. Pituitary deficits can evolve over time, with unpredictable patterns resulting in significant morbidity and mortality. Hypopituitarism and hypothalamic dysfunction may be associated with challenging comorbidities such as obesity, learning difficulties, behavioral issues, sleep disturbance, and visual impairment. Transition is the purposeful planned movement of adolescents and young adults with chronic conditions from child-centered to adult-oriented health care systems with a shift from parent- to patient-focused care. To achieve effective transition within a health care setting, the inherent challenges involved in the evolution from a dependent child to an independent adult must be recognized. Transition is a critical time medically for patients with hypopituitarism. Complex issues with respect to puberty, attainment of optimal stature, adherence to treatment, and acceptance of the need for life-sustaining medications need to be addressed. For health care professionals, transition is an opportunity for reassessment of the pituitary deficits and the need for lifelong replacement therapies, often against a background of complex psychological issues. We present 4 illustrative cases of hypopituitarism of differing etiologies with diverse clinical presentations. Diagnostic and management processes from clinical presentation to young adulthood are discussed, with a particular focus on needs and outcomes through transition.
引用
- Cerbone M, Katugampola H, Simpson HL, et al. Approach to the Patient: Management of Pituitary Hormone Replacement Through Transition. J Clin Endocrinol Metab. 2022. PMID: 35262704. doi:10.1210/clinem/dgac129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。